2Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet ,2005, 366 : 1945-1953.
3Cervantes F, Alvarez-Larran A, Talarn C, et al. Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. Br J Haematol,2002, 118:786-790.
4Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon:IARC Press, 2001:3942.
5Teferi A. Recent progress in the pathogenesis and management of essential thrombocvthemia. Leuk Res.2001.25 :369-377.
6Chim CS, Kwong YL, Lie AK, et al. Long-term outcome of 231 patients with essential thrombocythemia. Arch Intern Meal,2005, 165 : 2651-2658.
7Teferi A, Murphy S. Current opinion in essential thrombocythemia: pathogensis, diagnosis, and management. Blood Rev, 2001,15 : 121-131.
8Barbui T, Barosi G, Grossi A, et al. Practice guidelines for the therapy of essential thrombocythemia. Haematologica, 2004, 89 : 215-232.
